We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Xybion Digital Inc | TSXV:XYBN | TSX Venture | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.90 | 0.61 | 0.90 | 0 | 01:00:00 |
From Sep 2021 to Sep 2024
TORONTO, Nov. 22, 2021 /CNW/ - Dr. Pradip Banerjee, Chair and Chief Executive Officer, Xybion Digital Inc. ("Xybion" or the "Company") (TSXV: XYBN) and his team joined Omar Khafagy, Manager, Corporate Access, TMX Group, to celebrate the Company's new listing on the TSX Venture Exchange and to close the market.
Xybion is a global SaaS company that helps enterprise life sciences organizations accelerate new drug development into approved medicines that save lives and keep employees safe. They digitize drug research and development, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a single, unified cloud platform that is cost-effective, ready to deploy, and easy to use. Xybion has over 160 clients in 25 countries using its low-code software to accelerate timelines, improve compliance, expand capacity, minimize operating risks, and reduce expenses while keeping employees safe. For more information please visit https://www.xybion.com.
SOURCE TSX Venture Exchange
Copyright 2021 Canada NewsWire
1 Year Xybion Digital Chart |
1 Month Xybion Digital Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
